Clinical Efficacy and Safety of Brihat Gangadhara Churna in the Management of Irritable Bowel Syndrome: A Prospective Open-label Study

2019 ◽  
Vol 3 (3) ◽  
pp. 92-99
Author(s):  
Narayanam Srikanth ◽  
Shruti Khanduri ◽  
Rakesh Rana ◽  
Richa Singhal ◽  
Bhagwan Sahai Sharma ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Efficacy ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Irritable Bowel

Clinical Efficacy and Safety of Brahma Rasayana in Apparently Healthy Elderly Persons: A Prospective Multicenter Open-label Study

2018 ◽  
Vol 2 (4) ◽  
pp. 217-224
Author(s):  
Pradeep Dua ◽  
Rakesh Rana ◽  
Richa Singhal ◽  
Bhagwan Sahai Sharma ◽  
G Venkateswarlu ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Elderly Persons ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Healthy Elderly ◽  
Apparently Healthy

An open label study to determine the efficacy and tolerability of tegaserod in the treatment of constipation dominant irritable bowel syndrome (IBS-C)

2003 ◽  
Vol 124 (4) ◽  
pp. A533 ◽  
Author(s):  
Hasnain A. Shah ◽  
Wasim Jafri ◽  
Javed A. Butt ◽  
Aftab Mohsin ◽  
Ikramullah Khan
Keyword(s):  
Irritable Bowel Syndrome ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Irritable Bowel

scholarly journals Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS—Results from an Open Label Study

2021 ◽  
Vol 10 (19) ◽  
pp. 4317
Author(s):  
Lucyna Ostrowska ◽  
Diana Wasiluk ◽  
Camille F. J. Lieners ◽  
Mirosława Gałęcka ◽  
Anna Bartnicka ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Control Diet ◽  
Dietary Treatment ◽  
Control Group ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Irritable Bowel ◽  
Fodmap Diet

Irritable bowel syndrome (IBS) is a chronic disease with recurrent abdominal pain, disturbed bowel emptying, and changes in stool consistency. We compared the effectiveness of three different dietary treatment plans (G1-FM-low FODMAP diet, G2-IP IgG based elimination-rotation-diet, and as control group, the G3-K control diet recommended by an attending gastroenterologist) in treating patients diagnosed with mixed irritable bowel syndrome. A total of seventy-three female patients diagnosed with a mixed form of irritable bowel syndrome (IBS-M) were enrolled in the study. The diet of each patient in Group 1 (G1-FM) and 2 (G2-IP) was determined individually during a meeting with a dietitian. Patients from Group 3 (G3-K) received nutrition advice from a gastroenterologist. Significant differences in the reduction of IBS symptoms were found between the groups. IBS symptoms as well as comorbid symptoms significantly improved or disappeared completely in the G2-IP group (idiopathic abdominal pain, p < 0.001; abdominal pain after a meal, p < 0.001; abdominal pain during defecation, p = 0.008), while in the G1-FM group, some of the IBS symptoms significantly improved (mucus in stool, p = 0.031; bloating, p < 0.001). In group G3-K no significant improvement was seen. Based on the results of this open-label study, it was concluded that various dietary interventions in the treatment of IBS-M patients do not uniformly affect the course and outcomes of disease management. Rotation diets based on IgG show significantly better results compared to other diets.

Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan

2014 ◽  
Vol 20 (9) ◽  
pp. 535-540 ◽  
Author(s):  
Akihiko Morita ◽  
Satoshi Kamei ◽  
Masayuki Minami ◽  
Kazuto Yoshida ◽  
Satoshi Kawabata ◽  
...  
Keyword(s):  
Bacterial Meningitis ◽  
Clinical Efficacy ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Clinical Efficacy and Safety of Sarasvata Ghrita in the Management of Cognitive Deficit–A Prospective Open Label Study

2018 ◽  
Vol 2 (2) ◽  
pp. 63-69
Author(s):  
Shweta Chaudhary ◽  
Chandra Shekhar Rao ◽  
Srinibash Sahu ◽  
Hemant K Gupta ◽  
Guru Charan Bhuyan
Keyword(s):  
Clinical Efficacy ◽  
Cognitive Deficit ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document